Immunologic reconstitution after human marrow graftingWITHERSPOON, R. P; LUM, L. G; STORB, R et al.Seminars in hematology. 1984, Num 21, pp 2-10, issn 0037-1963Article

T cell reconstitution after bone marrow transplantation into adult patients does not resemble T cell development in early lifeSTOREK, J; WITHERSPOON, R. P; STORB, R et al.Bone marrow transplantation (Basingstoke). 1995, Vol 16, Num 3, pp 413-425, issn 0268-3369Article

Risk factors for the development of secondary malignancies after marrow transplantationDEEG, H. J; WITHERSPOON, R. P.Hematology/oncology clinics of North America. 1993, Vol 7, Num 2, pp 417-429, issn 0889-8588Article

Low IgG production by mononuclear cells from marrow transplant survivors and from normal neonates is due to a defect of B cellsSTOREK, J; WITHERSPOON, R. P; LUTHY, D et al.Bone marrow transplantation (Basingstoke). 1995, Vol 15, Num 5, pp 679-684, issn 0268-3369Article

Immunoglobulin synthesis after HLA-identical marrow grafting. V: The role of peripheral blood monocytes in the regulation of in vitro immunoglobulin secretion stimulated by pokeweed mitogenSHIOBARA, S; WITHERSPOON, R. P; LUM, L. G et al.The Journal of immunology (1950). 1984, Vol 132, Num 6, pp 2850-2856, issn 0022-1767Article

Lack of B cell precursors in marrow transplant recipients with chronic graft-versus-host diseaseSTOREK, J; WITHERSPOON, R. P; WEBB, D et al.American journal of hematology. 1996, Vol 52, Num 2, pp 82-89, issn 0361-8609Article

Proliferative and differentiative responses of B cells from human marrow graft recipients to T cell-derived factorsMATSUE, K; LUM, L. G; WITHERSPOON, R. P et al.Blood. 1987, Vol 69, Num 1, pp 308-315, issn 0006-4971Article

Efficacy of donor vaccination before hematopoietic cell transplantation and recipient vaccination both before and early after transplantationSTOREK, J; DAWSON, M. A; BOECKH, M et al.Bone marrow transplantation (Basingstoke). 2004, Vol 33, Num 3, pp 337-346, issn 0268-3369, 10 p.Article

Solid cancers after bone marrow transplantationCURTIS, R. E; ROWLINGS, P. A; FRAUMENI, J. F et al.The New England journal of medicine. 1997, Vol 336, Num 13, pp 897-904, issn 0028-4793Article

Allogeneic marrow transplantation for refractory anemia : a comparison of two preparative regimens and analysis of prognostic factorsANDERSON, J. E; APPELBAUM, F. R; DONEY, K et al.Blood. 1996, Vol 87, Num 1, pp 51-58, issn 0006-4971Article

Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndromeANDERSON, J. E; APPELBAUM, F. R; MARTIN, P. J et al.Blood. 1993, Vol 82, Num 2, pp 677-681, issn 0006-4971Article

Long-term survival and cure after marrow transplantation for congenital hypoplastic anaemia (Diamond-Blackfan syndrome)GREINIX, H. T; STORB, R; SANDERS, J. E et al.British journal of haematology. 1993, Vol 84, Num 3, pp 515-520, issn 0007-1048Article

Acute graft-versus-host disease : analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexateNASH, R. A; PEPE, M. S; MARTIN, P. J et al.Blood. 1992, Vol 80, Num 7, pp 1838-1845, issn 0006-4971Article

Marrow grafting for acute leukemia: results and future treatment strategiesSTORB, R; BUCKNER, C. D; SULLIVAN, K. M et al.Haematology and blood transfusion. 1990, Vol 33, pp 629-635, issn 0171-7111Article

Use of thymic grafts or thymic factors to augment immunologic recovery after bone marrow transplantation: brief report with 2 to 12 years's follow-upWITHERSPOON, R. P; SULLIVAN, K. M; LUM, L. G et al.Bone marrow transplantation (Basingstoke). 1988, Vol 3, Num 5, pp 425-435, issn 0268-3369Article

Second marrow transplants in patients with aplastic anemia rejecting the first graft: use of a conditioning regimen including cyclophosphamide and antithymocyte globulinSTORB, R; WEIDEN, P. L; SANDERS, J. E et al.Blood. 1987, Vol 70, Num 1, pp 116-121, issn 0006-4971Article

Marrow transplantation from HLA-identical siblings for treatment of aplastic anemia: is exposure to marrow donor blood products 24 hours before high-dose cyclophosphamide needed for successful engraftment? = Transplantation de mode de parents compatibles dans le système HLA dans le traitement des anémies aplasiques: l'exposition aux éléments sanguins de moelle du donneur 24 heures avant l'administration de hautes doses de cyclophosphamide est-elle nécessaire à la prise de la greffe?STORB, R; PRENTICE, R. L; CLIFT, R. A et al.Blood. 1983, Vol 61, Num 4, pp 672-675, issn 0006-4971Article

Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of Graft-Versus-host disease : A prospective, randomized trialDEEG, H. J; LIN, D; NASH, R et al.Blood. 1997, Vol 89, Num 10, pp 3880-3887, issn 0006-4971Article

Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host diseaseSTOREK, J; GOOLEY, T; HANSEN, J. A et al.Blood. 1997, Vol 90, Num 12, pp 4705-4709, issn 0006-4971Article

Treatment of acute graft-versus-host disease with humanized anti-Tac : an antibody that binds to the interleukin-2 receptorANASETTI, C; HANSEN, J. A; SULLIVAN, K. M et al.Blood. 1994, Vol 84, Num 4, pp 1320-1327, issn 0006-4971Article

Etoposide, cyclophosphamide and fractionated total body irradiation as a preparative regimen for marrow transplantation in patients with advanced hematological malignancies : a phase I studyPETERSEN, F. B; BUCKNER, C. D; HANSEN, J. A et al.Bone marrow transplantation (Basingstoke). 1992, Vol 10, Num 1, pp 83-88, issn 0268-3369Article

Gynecological abnormalities following allogeneic bone marrow transplantationSCHUBERT, M. A; SULLIVAN, K. M; THOMAS, E. D et al.Bone marrow transplantation (Basingstoke). 1990, Vol 5, Num 6, pp 425-430, issn 0268-3369, 6 p.Article

Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantationSULLIVAN, K. M; KOPECKY, K. J; BUDINGER, M. D et al.The New England journal of medicine. 1990, Vol 323, Num 11, pp 705-712, issn 0028-4793, 8 p.Article

Deletion of immunosuppressive prophylaxis after marrow transplantation increases hyperacute graft-versus-host disease but does not influence chronic graft-versus-host disease or relapse in patients with advanced leukemiaSULLIVAN, K. M; STORB, R; FISHER, L et al.Clinical transplantation. 1989, Vol 3, Num 1, pp 5-11, issn 0902-0063Article

Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical sibling as treatment of acute and chronic leukemiaSULLIVAN, K. M; WEIDEN, P. L; BEATTY, P et al.Blood. 1989, Vol 73, Num 6, pp 1720-1728, issn 0006-4971Article